Cargando…
Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19
In the context of the coronavirus disease 2019 (COVID-19) pandemic, we aimed to evaluate the impact of anti-cytokine therapies (AT) in kidney transplant recipients requiring hospitalization due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This is an observational retros...
Autores principales: | Bodro, Marta, Cofan, Frederic, Ríos, Jose, Herrera, Sabina, Linares, Laura, Marcos, María Angeles, Soriano, Alex, Moreno, Asunción, Diekmann, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067800/ https://www.ncbi.nlm.nih.gov/pubmed/33917093 http://dx.doi.org/10.3390/jcm10081551 |
Ejemplares similares
-
BK Virus and Cytomegalovirus Coinfections in Kidney Transplantation and Their Impact on Allograft Loss
por: Herrera, Sabina, et al.
Publicado: (2021) -
A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients
por: Linares, Laura, et al.
Publicado: (2021) -
863. ELISpot-BK virus assay for the assesment of BK virus cell-mediated immunity in kidney recipients
por: Herrera, Sabina, et al.
Publicado: (2023) -
Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection
por: Cacho, Judit, et al.
Publicado: (2022) -
Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation
por: Sanclemente, Gemma, et al.
Publicado: (2019)